Swiggy
neutral mediumSwiggy reported Q4 FY26 results with a focus on quick commerce (QC) achieving contribution margin break-even in March, exiting at +110 bps CM.
Read Swiggy analysis →Side-by-side earnings comparison across verified financials, AI summaries, management guidance, risks, quotes, and accountability signals.
Swiggy reported Q4 FY26 results with a focus on quick commerce (QC) achieving contribution margin break-even in March, exiting at +110 bps CM.
Read Swiggy analysis →SRF delivered a strong FY26 with revenue of ₹15,787 crore (+7% YoY), EBITDA of ₹3,800 crore (+29% YoY), and PAT of ₹1,835 crore (+47% YoY), driven by record fluoro-chemicals performance and margin expansion.
Read SRF analysis →Swiggy reported Q4 FY26 results with a focus on quick commerce (QC) achieving contribution margin break-even in March, exiting at +110 bps CM. Food delivery grew 18-20% YoY, with steady-state margins of 5%. QC GOV reached ₹1 lakh crore medium-term ambition, driven by differentiation via private labels (e.g., 'Noise') and improved take rates. Management emphasized balancing growth and profitability, deliberately churning low-AOV users to improve unit economics. MTU additions slowed to 0.5M net, but high-value cohorts retained well. Risks include sustained competitive intensity from multiple players, which could pressure marketing spend and delay EBITDA profitability. Capex is moderating after warehousing investments.
SRF delivered a strong FY26 with revenue of ₹15,787 crore (+7% YoY), EBITDA of ₹3,800 crore (+29% YoY), and PAT of ₹1,835 crore (+47% YoY), driven by record fluoro-chemicals performance and margin expansion. The chemicals business grew 16% to ₹7,779 crore, while performance films and technical textiles showed recovery. Management guided for 15-20% growth in chemicals in FY27, supported by HFC debottlenecking, specialty chemicals recovery, and new capacities (HFO, fluoropolymers, BOPP). Key risks include geopolitical disruptions in the Middle East, forex mark-to-market losses, and pricing pressure in specialty chemicals from Chinese competition.
Exited March at positive contribution margin, ahead of Q1 guidance.
Ambition to reach ₹1 lakh crore GOV in 3.5-5 years, implying 35-50% CAGR.
Deliberate churn of low-AOV users; high-value cohorts retained.
Non-GOV revenue (ads, etc.) at ~30% of GOV, expected to stay 30-40%.
Debottlenecking investment of ₹88 crore to increase HFC capacity beyond 65,000 metric tons per annum.
New site in Odisha for 20,000 MTPA HFO capacity, backward integration, and electronic grade HF.
Capital and revenue R&D spend in FY26; 40 patents filed, cumulative 521 filed.
Aligned with long-term growth priorities including HFO, fluoropolymers, and pharma intermediates.
Management confirmed achieving contribution margin break-even for the full quarter in Q1 FY27, with March exit at +110 bps.
Management guidance marginsTarget to reach ₹1 lakh crore GOV in 3.5-5 years, implying 35-50% CAGR, driven by store densification and geographic expansion.
Management guidance growthFood delivery business expected to maintain steady-state EBITDA margin of 5% with medium-term growth of 18-20%.
Management guidance marginsCapex expected to decline as warehousing investments are largely complete; Q4 capex was ~₹195 Cr.
Management guidance capexManagement expects the chemicals segment to grow 15-20% in FY27, driven by HFC volumes, specialty recovery, and new capacities.
Management guidance revenueThe new HFO plant in Odisha is expected to be commissioned by February 2028, with all three products coming up in parallel.
Management guidance expansionThe new BOPP line is on track to start production in July 2026, strengthening the packaging films portfolio.
Management guidance expansionA state-of-the-art polyamide line, India's first based on simultaneous stretching, will be operational by September 2027 with an investment of ₹180 crore.
Management guidance expansionMultiple players (6-7) remain aggressive, potentially pressuring marketing spend and delaying EBITDA profitability.
high · analyst_questionDeliberate churn of low-AOV users may suppress MTU growth for another two quarters, impacting top-line momentum.
medium · management_commentaryMarch LPG shortage caused <0.5% price increase; situation easing but could recur.
low · management_commentaryToy (low-price food app) is early-stage; cannibalization risk and unclear path to profitability.
medium · analyst_questionSales into the Middle East were impacted in Q4 due to geopolitical tensions, though management rerouted shipments to other markets.
medium · management_commentarySharp rupee depreciation led to mark-to-market losses on forward hedges, impacting FY26 results and expected to persist near-term.
medium · management_commentaryAggressive Chinese pricing has compressed margins in specialty chemicals; management expects normalization but timing uncertain.
high · analyst_questionGovernment has not clarified whether HCFC production will be included in baseline quota calculations, creating regulatory risk for HFC capacity expansion.
medium · analyst_questionWe are not going to take the route of buying growth.
If fighting for short-term relevance and going after spending in places that will hurt us later, I think that will compromise our long-term relevance.
We believe that the company should be able to deliver growth in the region of 15 to 20% in the coming year.
Our ability to reposition has ensured that we stayed strong in terms of the outcome for Q4.